The pharmaceutical industry trade balance in Belgium was valued at 30.00 billion USD in 2023, showing a positive trajectory over the next five years based on forecasted data. The values are expected to rise to 35.09 billion USD in 2024, 40.72 billion USD in 2025, 46.08 billion USD in 2026, 51.21 billion USD in 2027, and 56.09 billion USD in 2028. This indicates a continuous upward trend with notable year-on-year percentage increases.
Year-on-year variation analysis from 2024 to 2028:
- 2024: +16.97%
- 2025: +16.05%
- 2026: +13.16%
- 2027: +11.15%
- 2028: +9.53%
The Compound Annual Growth Rate (CAGR) from 2023 to 2028 stands at approximately 13.49%, indicating a steady average annual increase over the five-year period.
Future trends to watch for include advancements in pharmaceutical technologies, regulatory changes, and global trade dynamics, which might affect production costs and market access. Additionally, the influence of global health initiatives and emerging markets could provide further opportunities for growth in Belgium's pharmaceutical trade balance.
